Whether you wait for retatrutide, start an existing GLP-1 medication, or focus purely on lifestyle changes, the work is still on you
In a study of overweight and obese patients with asthma, an exercise intervention led to a reduction in eosinophilic airway inflammation, even though there was only modest weight loss [75]
Semaglutide and Tirzepatide are revolutionary medications that gained popularity for their ability to aid in weight loss by suppressing
GLP-1 receptor agonist medications mimic this hormone at therapeutic levels, meaning they amplify these effects in a way that supports meaningful, sustained weight loss
For example, the FDAs approval of Lillys ZepBound (tirzepatide for chronic weight management) in late 2023 was based on phase III data showing superior weight loss compared to placebo
I dont agree, and would not claim that at this point